High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients

BACKGROUND: The study aimed to detect the serum levels of fibroblast growth factor-21 (FGF-21) in fatty pancreas (FP) patients and to investigate their potential clinical value. METHODS: We screened patients with FP using transabdominal ultrasound. The anthropometric, biochemical and serum levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Fei, Yin, Ling, Yu, Xiaoping, Xu, Renyan, Tian, Mingxiang, Liu, Xinnong, Zhou, Lu, Hu, Lianghao, Gong, Weijuan, Xiao, Weiming, Lu, Guotao, Yao, Guanghuai, Ding, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105565/
https://www.ncbi.nlm.nih.gov/pubmed/37070097
http://dx.doi.org/10.7717/peerj.15176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105565/
https://www.ncbi.nlm.nih.gov/pubmed/37070097
http://dx.doi.org/10.7717/peerj.15176

Ejemplares similares